Article
Transport of SN-38 by the wild type of human ABC transporter ABCG2 and its inhibition by quercetin, a natural flavonoid.
Journal of experimental therapeutics & oncology - 1 Apr 2004
Yoshikawa Megumi, Ikegami Yoji, Sano Kazumi, Yoshida Hisahiro, Mitomo Hideyuki, Sawada Seigo, Ishikawa Toshihisa
Abstract excerpt
Irinotecan (CPT-11) is a widely-used potent anticancer drug that inhibits mammalian DNA topoisomerase I, however overexpression of the ATP-binding cassette transporter ABCG2 can confer cancer cells resistance to SN-38, the active form of CPT-11. In the present study, we have examined the contribution of three variant forms of ABCG2 to SN-38 resistance. Exogenous expression of the Arg482 (wild type), Gly482, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
